4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-14-053419
CIK 0001009356operating
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:08 PM ET
Size
22.4 KB
Accession
0001209191-14-053419
Insider Transaction Report
Form 4
CHAPPELL JOHN F
Director
Transactions
- Gift
Common Stock
2014-04-03−3,225→ 46,775 total(indirect: By GRAT) - Gift
Common Stock
2014-04-15−1,290→ 43,550 total(indirect: By GRAT) - Gift
Common Stock
2014-04-29−2,580→ 40,325 total(indirect: By GRAT) - Gift
Common Stock
2014-04-17−645→ 42,905 total(indirect: By GRAT) - Gift
Common Stock
2014-05-09−645→ 38,390 total(indirect: By GRAT) - Gift
Common Stock
2014-06-04−1,290→ 0 total(indirect: By GRAT) - Gift
Common Stock
2014-04-04−1,935→ 44,840 total(indirect: By GRAT) - Gift
Common Stock
2014-05-02−1,290→ 39,035 total(indirect: By GRAT) - Gift
Common Stock
2014-08-15−24,944→ 275,935 total - Gift
Common Stock
2014-08-15−200,000→ 300,879 total - Gift
Common Stock
2014-08-15+24,944→ 33,144 total(indirect: By Spouse)
Holdings
- 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The GRAT terminated on June 4, 2014. The remaining 37,100 shares in the GRAT were previously distributed to the reporting person and are reported in this Form 4 as directly owned.
- [F2]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 5:08 PM ET
- Size
- 22.4 KB